HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset.

AbstractPURPOSE:
Coronavirus disease 2019 (COVID-19) is creating an unprecedented healthcare crisis. Understanding the determinants of mortality is crucial to optimise intensive care unit (ICU) resource use and to identify targets for improving survival.
METHODS:
In a multicentre retrospective study, we included 379 COVID-19 patients admitted to four ICUs between 20 February and 24 April 2020 and categorised according to time from disease onset to ICU admission. A Cox proportional-hazards model identified factors associated with 28-day mortality.
RESULTS:
Median age was 66 years (53-68) and 292 (77%) were men. The main comorbidities included obesity and overweight (67%), hypertension (49.6%) and diabetes (30.1%). Median time from disease onset (i.e., viral symptoms) to ICU admission was 8 (6-11) days (missing for three); 161 (42.5%) patients were admitted within a week of disease onset, 173 (45.6%) between 8 and 14 days, and 42 (11.1%) > 14 days after disease onset; day 28 mortality was 26.4% (22-31) and decreased as time from disease onset to ICU admission increased, from 37 to 21% and 12%, respectively. Patients admitted within the first week had higher SOFA scores, more often had thrombocytopenia or acute kidney injury, had more limited radiographic involvement, and had significantly higher blood IL-6 levels. Age, COPD, immunocompromised status, time from disease onset, troponin concentration, and acute kidney injury were independently associated with mortality.
CONCLUSION:
The excess mortality in patients admitted within a week of disease onset reflected greater non-respiratory severity. Therapeutic interventions against SARS-CoV-2 might impact different clinical endpoints according to time since disease onset.
AuthorsElie Azoulay, Muriel Fartoukh, Michael Darmon, Guillaume Géri, Guillaume Voiriot, Thibault Dupont, Lara Zafrani, Lola Girodias, Vincent Labbé, Martin Dres, Alexandra Beurton, Antoine Vieillard-Baron, Alexandre Demoule
JournalIntensive care medicine (Intensive Care Med) Vol. 46 Issue 9 Pg. 1714-1722 (Sep 2020) ISSN: 1432-1238 [Electronic] United States
PMID32780165 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Interleukin-6
  • Troponin
Topics
  • Age Factors
  • Betacoronavirus
  • COVID-19
  • Comorbidity
  • Coronavirus Infections (mortality)
  • Female
  • France (epidemiology)
  • Humans
  • Intensive Care Units (statistics & numerical data)
  • Interleukin-6 (blood)
  • Male
  • Middle Aged
  • Organ Dysfunction Scores
  • Pandemics
  • Pneumonia, Viral (mortality)
  • Proportional Hazards Models
  • Real-Time Polymerase Chain Reaction
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Time Factors
  • Time-to-Treatment
  • Troponin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: